MED vs QDEL
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
MED
QDEL
Investment Advisor Scores
QDEL
AI Analyst Insights
Detailed Metrics Comparison
| Metric | MED | QDEL | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 12.4844 | 9.5877 | QDEL |
| PEG Ratio | 0.972 | 2.0638 | MED |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -19.4% | -11.6% | QDEL |
| Earnings Growth | -87.2% | -77.1% | QDEL |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 39.2/100 | 41.8/100 | QDEL |
| Profit Margin | -13.6% | -14.2% | MED |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | QDEL |
Relative Price Performance (Last 90 Days)
Current Technical Phase
MED
MarkupPrice above SMA50, rising 50-day trend (1.9% over 20 days), RSI 57
QDEL
MarkdownPrice below a falling SMA50 (slope -4.2%), weak momentum, RSI 38
Fundamentals Snapshot
| Metric | MED | QDEL |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -321.5 | 8.1 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.2% | -0.1% |
| Gross Margin | 0.7% | 0.4% |
| Operating Margin | -0.1% | 0.0% |
| EPS | -3.70 | -5.39 |
| Dividend Yield | — | — |